Cite Filings / ALKS / 0001193125-26-319022
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Alkermes plc. · Filed 2026-07-28 · Acc 0001193125-26-319022

Documents 1

  • 10-Q Quarterly Report , alks-20260630.htm

Around this filing

  • 2026-11-03 10-Q Quarterly Report
  • 2026-08-03 4 EVP R&D, Chief Medical Officer sold 9,000 shares at $48.58 ($437,220)
  • 2026-08-03 4 EVP, CLO, Alkermes, Inc. sold 2,034 shares at $48.58 ($98,812)
  • 2026-07-28 S-8 Securities Offered to Employees in Benefit Plans
  • 2026-07-28 10-Q Quarterly Report
  • 2026-07-28 8-K Results of operations
  • 2026-05-05 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading alks-20260630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…